Purpose: To evaluate the safety, efficacy, and predictability of excimer laser in situ keratomileusis (LASIK) to correct residual myopia and astigmatism after penetrating keratoplasty (PKP).
Setting: Buzard Eye Institute, Las Vegas, Nevada, USA.
Methods: Twenty-six eyes had LASIK at least 1 year after PKP.